GSK Unit Loses Appeal Bid For 3D Purple Inhaler TM
European appellate officials have denied Glaxo Group's application for a 3D-shaped trademark of an inhaler, ruling that shoppers would associate the purple color with its ingredients rather than commercial origin as...To view the full article, register now.
Already a subscriber? Click here to view full article